14 October, 2025

“Spain has a great opportunity in the biopharmaceutical sector, but it must review its policies to maintain and increase its potential and attract investment in R&D and in industrial and digital assets.”

The president of Farmaindustria, Fina Lladós, calls for a regulatory framework that improves the country’s competitiveness in order to turn the current situation of global uncertainty […]
7 October, 2025

Spain consolidates its leadership in clinical trials with new guidelines promoting innovation, digitalisation and sustainability in hospital pharmacy

Pharmacists and industry present the updated “Guide to Excellence for Conducting Clinical Trials in Hospital Pharmacy” in Barcelona. This is another step towards excellence and improving […]
16 September, 2025

Farmaindustria welcomes the announcement by the Spanish Agency for Medicines and Health Products (AEMPS) to expand the accelerated assessment of early-stage clinical trials, as this strengthens the Spanish biomedical research ecosystem.

This “fast track” is one of the sector’s strategic measures in the field of biomedical research and is included in the National Pharmaceutical Industry Strategy. Patients […]